Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
From Basic Research to New Tools and Challenges for the Genotoxicity Testing of Nanomaterials
| From Basic Research to New Tools and Challenges for the Genotoxicity Testing of Nanomaterials |
| Autore | FESSARD Valérie |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 electronic resource (188 p.) |
| Soggetto topico |
Humanities
Social interaction |
| Soggetto non controllato |
graphene oxide
reduced graphene oxide micronucleus oxidative stress safer-by-design tungsten nanoparticles tritiated particles in vitro testing cytotoxicity micronuclei formation DNA damage epigenetics DNA methylation BEAS-2B cells polystyrene nanoparticles nanoplastics genotoxicity Hs27 human fibroblasts comet assay FPG enzyme TiO2NP SiO2NP ZnONP CeO2NP AgNP multi-walled carbon nanotubes (MWCNT) titanium dioxide nanoparticles lincomycin human amniotic cells in vitro genotoxicity apoptosis nanotoxicology metal oxides high throughput screening micronucleus assay nanomaterial aluminum oral route gut liver V79 cells Hprt advanced in vitro model hepatotoxicity liver spheroids 3D culture HepG2 nongenotoxic silver nanoparticles genotoxic cytotoxic antioxidant activity silver ions Allium cepa metal/coating agent ratio |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557414003321 |
FESSARD Valérie
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges
| Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges |
| Autore | Müller Rüdiger |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 electronic resource (260 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
rheumatoid arthritis
sleep sleep disorders pain osteoporosis fracture fracture risk assessment tool treat-to-target certolizumab pegol csDMARDs glucocorticoids intra-articular injections DAS 28 ACR response HAQ-DI TNFα golimumab efficacy tolerability immunogenicity methotrexate posology titration oral route subcutaneous route bioavailability effectiveness periodontitis periodontal disease anti-citrullinated protein autoantibodies rheumatoid factor smoking medication Porphyromonas gingivalis Rheumatoid arthritis matrix metalloproteinase 3 infliximab pharmacogenomics anti-TNF personalized medicine baricitinib disease-modifying antirheumatic drugs pain perception outcomes research patient perspective Rheumatoid Arthritis therapy DMARD MTX Tumor Necrosis Factor-Alpha Inhibitors ankylosing spondylitis biosimilar switching synovial fibroblasts cytokine osteoclast herbal medicine methylation next-generation sequencing recovery of function fatigue productivity tofacitinib oral Th1.17 IL-17A IFN-γ, CD73 adenosine psoriatic arthritis regulation pseudoerosions hand foot ultrasonography radiography computed tomography magnetic resonance imaging |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Rheumatoid Arthritis Therapy Reappraisal |
| Record Nr. | UNINA-9910557286503321 |
|
Müller Rüdiger
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||